David C Crossman

Title: **David C. Crossman: Innovator in Cardiovascular Diagnostics**

Introduction

David C. Crossman is a prominent inventor based in Sheffield, United Kingdom, known for his contributions to the field of cardiovascular diagnostics. With a total of four patents to his name, he has developed innovative methods that significantly enhance the diagnosis and treatment of heart-related disorders. His work is particularly focused on identifying complications related to myocardial infarction and developing predictive tools for associated cardiovascular conditions.

Latest Patents

Among his latest inventions is a patent describing a method for diagnosing myocardial infarction. This invention encompasses a range of kits and methodologies aimed at diagnosing various cardiovascular disorders. Notably, it includes a method and kit for determining whether a subject suffers from a fragile plaque disorder, an occlusive disorder, or a restenosis disorder. Furthermore, Crossman's work also extends to methods related to selecting therapeutics for patients diagnosed with cardiovascular diseases.

Another significant patent involves diagnostics and therapeutics for restenosis. This invention provides comprehensive methods and kits to identify whether an individual has or is at risk of developing restenosis, highlighting the innovative nature of Crossman’s research.

Career Highlights

David C. Crossman is currently associated with Interleukin Genetics, Inc., where he applies his expertise to advancing cardiac health. His career has been marked by a commitment to improving patient outcomes in cardiovascular health, leading to numerous groundbreaking patents that reflect his dedication to innovation in this critical field.

Collaborations

Crossman often collaborates with distinguished colleagues including Sheila E. Francis and Gordon W. Duff. These collaborations have further enriched his inventions, combining diverse expertise to enhance the effectiveness of cardiovascular diagnostics and therapies.

Conclusion

David C. Crossman stands out as a significant figure in the realm of cardiovascular innovation. His patents not only advance our understanding of heart diseases but also pave the way for more effective diagnostic tools and treatment options. As he continues his work at Interleukin Genetics, Inc., the impact of his innovations will undoubtedly contribute to the ongoing pursuit of excellence in cardiovascular health.